News | Lung Imaging | March 11, 2016

Researchers Make Major Breakthrough in New Lung MRI Scan Technology

Clean energy combustion technology has been used to successfully hyperpolarize krypton gas for MRI scanning of the lungs

lung disease, MRI scans, contrast agent, hyperpolarized krypton

March 11, 2016 — New scanning technology which will give a much clearer picture of lung disease has taken a major step forward thanks to scientists at The University of Nottingham.

The experts at the Sir Peter Mansfield Imaging Centre have developed a process using specially treated krypton gas as an inhalable contrast agent to make the spaces inside the lungs show up on a magnetic resonance imaging (MRI) scan. It is hoped the new process will eventually allow doctors to virtually see inside the lungs of patients.

Traditional MRI uses hydrogen protons in the body as molecular targets to give a picture of tissue, but this does not give a detailed picture of the lungs because they are full of air. Recent technological developments have led to a novel imaging methodology called inhaled hyperpolarized gas MRI that uses lasers to 'hyperpolarize' a noble (inert) gas which aligns (polarizes) the nuclei of the gas so it shows up on an MRI scan.

The work will make 3-D imaging using 'atomic spies' like helium, xenon or krypton possible in a single breath hold by the patient. Nottingham has pioneered hyperpolarized krypton MRI and is currently advancing this technology towards the clinical approval processes.

Hyperpolarized MRI research has been trying to overcome a problem with these noble gases retaining their hyperpolarized state for long enough for the gas to be inhaled, held in the lungs and scanned. Now in a paper published in the Proceedings of the National Academy of Sciences, the Nottingham team has developed a new technique to generate hyperpolarized krypton gas at high purity, a step that will significantly facilitate the use of this new contrast agent for pulmonary MRI.

Chair in Translational Imaging at the Sir Peter Mansfield Imaging Centre, Prof. Thomas Meersmann, said: "It is particularly demanding to retain the hyperpolarized state of krypton during preparation of this contrast agent. We have solved a problem by using a process that is usually associated with clean energy-related sciences. It's called catalytic hydrogen combustion. To hyperpolarize the krypton-83 gas we diluted it in molecular hydrogen gas for the laser pumping process. After successful laser treatment the hydrogen gas is mixed with molecular oxygen and literally exploded it away in a safe and controlled fashion through a catalyzed combustion reaction.

"Remarkably, the hyperpolarized state of krypton-83 survives the combustion event. Water vapor, the sole product of the 'clean' hydrogen reaction, is easily removed through condensation, leaving behind the purified laser-polarized krypton-83 gas diluted only by small remaining quantities of harmless water vapor. This development significantly improves the potential usefulness of laser-pumped krypton-83 as MRI contrast agent for clinical applications."

This new technique can also be used to hyperpolarize another useful noble gas, xenon-129, and may lead to a cheaper and easier production of this contrast agent.

As part of a recent Medical Research Council funding award, hyperpolarized krypton-83 is currently being developed for whole body MRI at high magnetic field strength in the Sir Peter Mansfield Imaging Centre's large 7 Tesla scanner. Studies will be carried out first on healthy volunteers before progressing to patient trials at a later phase.

For more information: www.pnas.org

Related Content

Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is
The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer | October 21, 2020
October 21, 2020 — Quantib, a market leader in...
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...